Monday 21 March 2022

Reuters Global Healthcare: Most unvaccinated children lack antibodies after COVID; GSK vaccine shows promise vs Omicron

Most unvaccinated children lack antibodies after COVID; GSK vaccine shows promise vs Omicron

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Rhode Island reaches $107 mln opioid settlements with drugmakers

Rhode Island's attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries and AbbVie's Allergan unit to resolve claims over their roles in fueling an opioid epidemic in the state.

Romania reports bird flu outbreak on farm near Bulgarian border - OIE

Romania has reported a new outbreak of highly pathogenic H5N1 avian influenza, commonly called bird flu, on a farm in the south of the country, the World Organisation for Animal Health (OIE) said on Monday.

Italy reports 32,573 coronavirus cases on Monday, 119 deaths

Italy reported 32,573 COVID-19 related cases on Monday, against 60,415 the day before, the health ministry said, while the number of deaths rose to 119 from 93.

FMC's U.S. division Health Partners in $2.4 bln three-way merger

Dialysis provider Fresenius Medical Care has agreed to merge its U.S. unit Fresenius Health Partners with medical services groups InterWell Health and Cricket Health to expand in the care of earlier stages of kidney disease.

U.S. FDA advisers to discuss COVID vaccine boosters in April

The U.S. drug regulator said on Monday a panel of independent advisers will meet on April 6 to discuss considerations for use of COVID-19 vaccine booster doses.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Indonesia scraps quarantine for overseas arrivals

Indonesia has removed its quarantine requirement for all arrivals from overseas, its tourism minister said on Monday, responding to improvements in its containment of the coronavirus

South Korea to buy 10 million doses of SK Bioscience's COVID vaccine

South Korea has reached a deal to buy 10 million doses of the country's first experimental coronavirus vaccine, developed by SK Bioscience Co Ltd , authorities said on Monday.

Moderna to supply additional 7 million doses of COVID booster vaccine to Switzerland

Moderna Inc said on Monday it has signed a new agreement with Switzerland for the supply of another seven million doses of its COVID-19 booster vaccine for delivery in 2023.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study